Effect of age and cancer on peripheral immune cell subsets and their PD-1 and PD-L1 expression
Year: 2015
Type: conference-abstract
Abstract: Meeting abstracts Immunotherapies aiming to interfere with the immune checkpoint molecule PD-1 (programmed death-1) and its ligand PD-L1 are currently being investigated in several clinical trials to treat cancer patients. Little is known about the effect of age or cancer on peripheral immune cell
Authors: Italia Grenga, Lauren Lepone, Renee Donahue, Jacob Richards, Simon Metenou, Christopher R Heery, Ravi Madan, James L Gulley, Jeffrey Schlom
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,490
OpenAlex ID: W2181833581
